HCPCS J Modifiers codes

Modifiers	Modifier description
J1	Competitive acquisition program no-pay submission for a prescription number
J2	Competitive acquisition program, restocking of emergency drugs after emergency administration
J3	Competitive acquisition program (cap), drug not available through cap as written, reimbursed under average sales price methodology
J4	Dmepos item subject to dmepos competitive bidding program that is furnished by a hospital upon discharge
JA	Administered intravenously
JB	Administered subcutaneously
JC	Skin substitute used as a graft
JD	Skin substitute not used as a graft
JE	Administered via dialysate
JF	Compounded drug
JG	Drug or biological acquired with 340b drug pricing program discount
JW	Drug amount discarded/not administered to any patient